Jamie Dananberg - Feb 16, 2024 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jennifer Lew, Attorney-in-Fact
Stock symbol
ANNX
Transactions as of
Feb 16, 2024
Transactions value $
$0
Form type
4
Date filed
2/21/2024, 04:32 PM
Previous filing
Aug 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANNX Common Stock Award $0 +39K $0.00 39K Feb 16, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Award $0 +160K $0.00 160K Feb 16, 2024 Common Stock 160K $5.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025.
F2 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.